Danske Bank’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Danske Bank's XENE Position: Q3 2026 in Review
Danske Bank held its Xenon Pharmaceuticals (XENE) position steady in Q3 2026 at 100 shares worth $3.72K. The position accounts for ﹤0.01% of the portfolio, ranked #925.
Danske Bank first reported a position in XENE in Q3 2024 and has held it in 7 quarters since. The position peaked at $35.9K in Q4 2025. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Danske Bank held 100 shares of Xenon Pharmaceuticals worth $3.72K as of Q3 2026.
- Danske Bank left its Xenon Pharmaceuticals share count unchanged in Q3 2026.
- Xenon Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #925 holding.
- Danske Bank first reported a position in Xenon Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
- Danske Bank's Xenon Pharmaceuticals position peaked at $35.9K in Q4 2025.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.